Upload Avatar (500 x 500)
谢晓慧
xxhrenee@bjmu.edu.cn
中文, 英文
北京
北京大学
Pharmaceutical Sciences
  • 1990年 - 北京大学药学院药学和临床药学理学学士和理学硕士学位
  • 1990年7月至2002年3月 - 北京积水潭医院 - 干部病房临床药师
  • 2002年3月至今 - 北京大学药学院 - 临床药学讲师和研究员
  • 2003年至今 - 北京地区执业药师继续教育任课教师
合理用药与药学服务(含儿科方向)
慢病管理
临床药学教育
  • The Transcultural Adaptation and Validation of the Chinese Version of the Duke Anticoagulation Satisfaction Scale, Yibo Wu, Shujie Dong, Xiaohui Xie, 2022
  • The impact of smoking status on the progression-free survival of non-small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta-analysis, Xinyi Li, Cong Huang, Xiaohui Xie, 2021
  • Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis, Xinyi Li, Ziyang Wu, Xiaohui Xie, 2021
  • Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non–small‐cell lung cancer patients: A network meta-analysis, Ziyang Wu, Suhua Chen, Xiaohui Xie, 2021
  • The efficacy and safety of three types of combination therapies in patients with moderate to very severe COPD: a systematic review and meta-analysis, Zhou R, Wang L, Sun T, Wu Z, Xie X, 2019
  • 药师处方权认知度和支持度的初步调查, 谢晓慧,吴一波,王利群,赵志刚,田月,乔宇,黄少军, 2019
  • Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: a systematic review and meta-analysis, Liqun Wang, Ruiui Zhou, Xiaohui Xie, 2019
  • Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis, Jiayu Cui, Ruiui Zhou, Sheng Han, Tiansheng Wang, Liqun Wang, Xiaohui Xie, 2018
  • Assessment of the quality of randomized controlled trials on pharmaceutical care for asthmatic patients in journals of mainland China, Wang L, Xie X, Zhou R, 2017
  • 互动教学在药物治疗学教学中的应用研究, 谢晓慧,王利群,崔家玉, 2017
合理用药 药学服务 儿科 慢病 管理 临床药学 教育 药物治疗 患者护理 医疗

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。